3M Work in process increased by 0.4% to $1.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $1.10B to $1.13B. Over 5 years (FY 2020 to FY 2025), Work in process shows relatively stable performance with a -1.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.34B | $1.44B | $1.58B | $1.67B | $1.79B | $1.83B | $1.61B | $1.55B | $1.53B | $1.49B | $1.42B | $1.39B | $1.19B | $1.19B | $1.05B | $1.10B | $1.13B | $1.15B | $1.13B | $1.13B |
| QoQ Change | — | +7.0% | +9.8% | +5.8% | +7.1% | +2.3% | -12.2% | -3.7% | -1.2% | -2.4% | -4.5% | -2.5% | -14.0% | -0.3% | -11.7% | +4.4% | +3.1% | +1.3% | -1.7% | +0.4% |
| YoY Change | — | — | — | — | +33.2% | +27.4% | +1.8% | -7.4% | -14.6% | -18.5% | -11.3% | -10.2% | -21.9% | -20.2% | -26.2% | -21.0% | -5.2% | -3.7% | +7.1% | +3.0% |
| % of Inventories | 27.7% | 29.0% | 31.6% | 31.6% | 31.7% | 32.6% | 29.9% | 29.1% | 28.9% | 29.4% | 29.5% | 28.3% | 29.4% | 29.5% | 28.4% | 28.4% | 27.7% | 29.4% | 30.8% | 30.6% |
| Share Change | — | +1.3pp | +2.6pp | -0.1pp | +0.1pp | +0.9pp | -2.7pp | -0.8pp | -0.2pp | +0.5pp | +0.1pp | -1.2pp | +1.0pp | +0.1pp | -1.0pp | -0.1pp | -0.6pp | +1.7pp | +1.3pp | -0.1pp |